UnitedHealth Group (NYSE:UNH) Trading 2.2% Higher Following Strong Earnings

UnitedHealth Group Incorporated (NYSE:UNH) shares shot up 2.2% on Wednesday following a stronger than expected earnings report. The company traded as high as $358.56 and last traded at $353.5130. 11,785,657 shares changed hands during trading, an increase of 21% from the average session volume of 9,730,898 shares. The stock had previously closed at $346.01.

The healthcare conglomerate reported $7.23 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.76 by $0.47. UnitedHealth Group had a return on equity of 14.65% and a net margin of 2.68%.The company had revenue of $111.65 billion for the quarter, compared to the consensus estimate of $109.84 billion. During the same quarter last year, the business posted $7.20 earnings per share. The firm’s revenue was up 2.0% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 17th. Investors of record on Monday, March 9th were given a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date was Monday, March 9th. UnitedHealth Group’s dividend payout ratio (DPR) is 67.02%.

Key Stories Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Q1 beat and raised guidance — UNH reported Q1 adjusted EPS of $7.23 (vs. consensus ~$6.76) and revenue of ~$111.7B, and raised FY‑2026 adjusted EPS guidance to above $18.25, citing improved management of medical costs. This is the main catalyst for the rally. Business Wire — Q1 Results
• Positive Sentiment: Analyst upgrades and price‑target increases — Multiple firms (Argus, RBC, Oppenheimer, Wells Fargo, Morgan Stanley, Jefferies, etc.) raised ratings or targets after the report, adding upward pressure as sell‑side momentum attracts buyers. 247wallst — Analyst Upgrades
• Positive Sentiment: AI & operational initiatives — Management flagged a meaningful AI investment (and Optum Real transaction scale), which investors view as a durable margin/efficiency tailwind if deployment scales as planned. That narrative supports higher multiple assumptions. Yahoo Finance — Q1 Deep Dive (AI)
• Positive Sentiment: Bullish options flow — Unusual activity: ~164k call options traded (≈30% above average), signaling short‑term bullish positioning from traders and institutional players.
• Neutral Sentiment: Sector sentiment spillover — UNH’s beat dragged peers higher (CVS, Humana, Centene); positive industry momentum can amplify the stock move but doesn’t change UNH’s fundamentals. Yahoo — Sector Impact
• Negative Sentiment: Ongoing risks remain — Management warned of challenges around a Medicare obesity‑drug pilot and cautioned that medical‑cost dynamics are still the key risk; if costs reaccelerate, margins and guidance could reverse. Reuters — Medicare Obesity Drug Pilot Challenges

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on UNH. Argus upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $400.00 price objective on the stock in a research report on Wednesday. Sanford C. Bernstein increased their price objective on UnitedHealth Group from $405.00 to $411.00 and gave the stock an “outperform” rating in a research report on Tuesday, April 7th. Evercore upgraded UnitedHealth Group to a “strong-buy” rating in a research report on Tuesday, January 6th. Raymond James Financial upgraded UnitedHealth Group from a “market perform” rating to an “outperform” rating and set a $330.00 price target on the stock in a research report on Wednesday, April 1st. Finally, HSBC upgraded UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $300.00 price target on the stock in a research report on Tuesday, April 7th. One investment analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, seven have issued a Hold rating and two have given a Sell rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $377.68.

Institutional Trading of UnitedHealth Group

Several large investors have recently modified their holdings of UNH. Brighton Jones LLC grew its stake in shares of UnitedHealth Group by 176.2% in the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock worth $22,384,000 after purchasing an additional 28,231 shares during the last quarter. Revolve Wealth Partners LLC grew its stake in shares of UnitedHealth Group by 137.1% in the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock worth $2,033,000 after purchasing an additional 2,324 shares during the last quarter. CMT Capital Markets Trading GmbH bought a new stake in shares of UnitedHealth Group in the second quarter worth about $340,000. Flow Traders U.S. LLC bought a new stake in shares of UnitedHealth Group in the second quarter worth about $356,000. Finally, Jump Financial LLC bought a new stake in shares of UnitedHealth Group in the second quarter worth about $377,000. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Stock Up 2.2%

The company has a 50 day moving average of $290.76 and a 200-day moving average of $317.09. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.80 and a quick ratio of 0.79. The company has a market capitalization of $320.88 billion, a P/E ratio of 26.70, a PEG ratio of 1.53 and a beta of 0.40.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.